85 related articles for article (PubMed ID: 2431775)
1. Central nervous system toxicity with fludarabine.
Merkel DE; Griffin NL; Kagan-Hallet K; Von Hoff DD
Cancer Treat Rep; 1986 Dec; 70(12):1449-50. PubMed ID: 2431775
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system toxicity of fludarabine phosphate.
Chun HG; Leyland-Jones BR; Caryk SM; Hoth DF
Cancer Treat Rep; 1986 Oct; 70(10):1225-8. PubMed ID: 2428492
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.
Spriggs DR; Stopa E; Mayer RJ; Schoene W; Kufe DW
Cancer Res; 1986 Nov; 46(11):5953-8. PubMed ID: 2428488
[TBL] [Abstract][Full Text] [Related]
4. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia.
Schilling PJ; Vadhan-Raj S
N Engl J Med; 1990 Sep; 323(12):833-4. PubMed ID: 1697401
[No Abstract] [Full Text] [Related]
5. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.
Warrell RP; Berman E
J Clin Oncol; 1986 Jan; 4(1):74-9. PubMed ID: 2416889
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity associated with fludarabine monophosphate.
Hurst PG; Habib MP; Garewal H; Bluestein M; Paquin M; Greenberg BR
Invest New Drugs; 1987; 5(2):207-10. PubMed ID: 2443463
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
List AF; Kummet TD; Adams JD; Chun HG
Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
[No Abstract] [Full Text] [Related]
8. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
[No Abstract] [Full Text] [Related]
9. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
[No Abstract] [Full Text] [Related]
11. Efficacy and neurotoxicity of ARA-AMP in CAH-B.
Lok A
Hepatology; 1990 Apr; 11(4):713. PubMed ID: 1691734
[No Abstract] [Full Text] [Related]
12. Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
Harvey WH; Fleming TR; Von Hoff DD; Katterhagen JG; Coltman CA
Cancer Treat Rep; 1987 Dec; 71(12):1319-20. PubMed ID: 2446754
[No Abstract] [Full Text] [Related]
13. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
Von Hoff DD; Kronmal R; O'Toole RV; Surwit EA; Hutton JJ; Alberts DS
Am J Clin Oncol; 1988 Apr; 11(2):146-8. PubMed ID: 2451882
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
Kraut EH; Crowley JJ; Grever MR; Keppen MD; Bonnet JD; Hynes HE; Salmon SE
Invest New Drugs; 1990 May; 8(2):199-200. PubMed ID: 1696569
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
Hochster H; Cassileth P
Semin Oncol; 1990 Oct; 17(5 Suppl 8):63-5. PubMed ID: 1699284
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
Weiss GB; Metch B; Von Hoff DD; Taylor SA; Saiers JH
Cancer Treat Rep; 1987 Dec; 71(12):1313-4. PubMed ID: 2446753
[No Abstract] [Full Text] [Related]
17. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.
Avramis VI; Champagne J; Sato J; Krailo M; Ettinger LJ; Poplack DG; Finkelstein J; Reaman G; Hammond GD; Holcenberg JS
Cancer Res; 1990 Nov; 50(22):7226-31. PubMed ID: 1699658
[TBL] [Abstract][Full Text] [Related]
18. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
[No Abstract] [Full Text] [Related]
19. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trials with fludarabine phosphate.
Von Hoff DD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):33-8. PubMed ID: 1699281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
